Woodbridge Liquidation Trust
Woodbridge Liquidation Trust (WBQNL) Financial Performance & Income Statement Overview
Review Woodbridge Liquidation Trust (WBQNL) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Woodbridge Liquidation Trust (WBQNL) Income Statement & Financial Overview
Review Woodbridge Liquidation Trust WBQNL income statement with detailed quarterly and annual figures.
Metric | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
---|---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
Gross Profit Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
Operating Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
Total Costs & Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
Depreciation & Amortization | $43276.00 | $43812.00 | -$39586.00 | $122085.00 |
EBITDA | $0.00 | $0.00 | $0.00 | $0.00 |
EBITDA Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
Operating Income | $0.00 | $0.00 | $0.00 | $0.00 |
Operating Income Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
Other Income/Expenses (Net) | $0.00 | $0.00 | $0.00 | $0.00 |
Income Before Tax | $0.00 | $0.00 | $0.00 | $0.00 |
Income Before Tax Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
Income Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 |
Net Income | $0.00 | $0.00 | $0.00 | $0.00 |
Net Income Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
EPS | $0.00 | $0.00 | $0.00 | $0.00 |
Diluted EPS | $0.00 | $0.00 | $0.00 | $0.00 |
Weighted Avg Shares Outstanding | $0.00 | $0.00 | $0.00 | $0.00 |
Weighted Avg Shares Outstanding (Diluted) | $0.00 | $0.00 | $0.00 | $0.00 |
Over the past four quarters, Woodbridge Liquidation Trust demonstrated steady revenue growth, increasing from $0.00 in Q2 2023 to $0.00 in Q1 2024. Operating income reached $0.00 in Q1 2024, maintaining a consistent N/A margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $0.00, reflecting operational efficiency. Net income rose to $0.00, with EPS at $0.00. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan